RecruitingNCT06167135

Polycystic Ovary Syndrome, Mitochondrial Dysfunction, Obesity, Insulin Resistance Infertility (POMODORI) Cohort

Polycystic Ovary Syndrome, Insulin Resistance, Infertility, Obesity, and the Associated Mitochondrial Dysfunction With These Disorders in Hungarian Patients


Sponsor

Semmelweis University

Enrollment

150 participants

Start Date

Sep 10, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

Enrolling of 150 female patients of fertile age diagnosed with PCOS, insulin resistance, infertility, or mitochondrial disease, and the same number of age- and sex-matched controls are planned. During the research biomarkers already with mitochondrial dysfunction in the scientific literature and common mtDNA abnormalities (deletions, point mutations, copy number changes, etc.) are examined.


Eligibility

Sex: FEMALEMin Age: 20 YearsMax Age: 45 Years

Inclusion Criteria4

  • Presence of polycystic ovary syndrome (PCOS) or insulin resistance (IR) associated with other multisystemic phenotypes, mitochondrial dysfunction
  • history of infertility associated with other multisystemic phenotypes, mitochondrial dysfunction
  • a known history of mitochondrial dysfunction and PCOS and/or IR
  • general health is good and there is no serious general medical condition that would prevent participation would make participation highly risky

Exclusion Criteria2

  • poor cooperation
  • refusal to participate in the study

Locations(1)

Semmelweis University

Budapest, Hungary

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06167135


Related Trials